MacroLux participated in the 34th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE 2025), held in Istanbul, Türkiye, from October 19–22, 2025.
The European Society for Gynaecological Endoscopy (ESGE) is a leading international organization dedicated to promoting minimally invasive gynecological surgery. Founded in 1990, ESGE brings together surgeons, researchers, and medical professionals from over 50 countries. This prestigious congress brought together leading experts, clinicians, and innovators from around the world to explore the latest advances in minimally invasive gynecological surgery.
At ESGE 2025, MacroLux Medical have demonstrated our concern for women's health through technological innovation. MacroLux Medical showcased its latest singel-use Hysteroscope, the SeleneView Single-Use Hysteroscope, featuring an ultra-slim 2.9 mm outer diameter designed to enhance patient comfort—requiring no cervical dilation, no anesthesia, and no speculum.
During the congress, the MacroLux Medical team engaged in in-depth discussions with leading experts from the United States, the United Kingdom, Spain, Italy, and Singapore, including Prof. Justin Clark, Prof. Linda Bradley, Prof. Jose “Tony” Carugno, and Prof. Attilio Di Spiezio Sardo. The experts highly recognized the innovative concept and clinical value of the SeleneView Single-Use Hysteroscope, noting that its pioneering design represents a new direction in minimally invasive gynecological diagnostics and treatment. They agreed that the SeleneView offers clinicians a more flexible and safer solution, advancing the field of women’s health through innovation.
Looking ahead, MacroLux Medical remains committed to collaborating with healthcare professionals to push the boundaries of innovation in women’s health.
ABOUT US
MacroLux is a company dedicated to endoscopic diagnosis and treatment, focused on providing innovative and reliable medical solutions to healthcare professionals around the world. We are focusing on the endoscopic intervention therapy market and prioritize the development of single-use electronic endoscope products.